North Korean IT Workers Frequently Infiltrate Crypto Firms, Lurk and Then Hack
On October 2, CoinDesk reported that more than a dozen cryptocurrency companies unknowingly hired IT workers from the Democratic People's Republic of Korea (DPRK), including established blockchain projects such as Injective, ZeroLend, Fantom, Sushi, Yearn Finance, and Cosmos Hub. Using fake IDs, these workers managed to pass interviews, pass background checks, and provide real work history.
Hiring North Korean workers is illegal in the U.S. and other countries that sanction North Korea, and multiple companies have hired and subsequently hacked North Korean IT workers. “Everyone is trying to filter out these people,” said Zaki Manian, a prominent blockchain developer. He inadvertently hired two North Korean IT workers to help develop the Cosmos Hub blockchain in 2021.
U.S. authorities have recently stepped up warnings that North Korean information technology (IT) workers are infiltrating tech companies and using the proceeds to fund nuclear weapons programs. An investigation revealed that North Korean job seekers are particularly aggressive and frequent in targeting cryptocurrency companies - successfully passing interviews, passing background checks, and even displaying an impressive history of code contributions on the open-source software repository GitHub.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
Crypto prices
More
